Cervical Transforaminal Injection of Steroids Guided by Ultrasound
Primary Purpose
Cervical Radiculopathy
Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
SNR steroid (dexamethasone) injection
CTF steroid (dexamethasone) injection
Dexamethasone
Ultrasound
C arm
Sponsored by
About this trial
This is an interventional treatment trial for Cervical Radiculopathy focused on measuring ultrasound, cervical Transformational Epidural Steroid Injection
Eligibility Criteria
Inclusion Criteria:
- evidence of a cervical radiculopathy involving 1 spinal nerve of at least 1 month's duration refractory to medical treatment
- symptoms of cervical pain radiating to the upper limb
- and signs of altered sensations, ab- normal reflexes, or motor weakness caused by degenerative spondylosis and/or disk herniation as documented at CT or MR imaging and a current mean pain VAS score of six.
Exclusion criteria:
- evidence of vertebral fracture, tumor, or infection of the cervical spine
- treatment with cervical corticosteroid injections within the past 3 months
- coagulopathy
- allergy to iodinated contrast media.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Experimental
Experimental
Experimental
Arm Label
USNR steroid injection
UCTF steroid injection
XCTF steroid injection
Arm Description
the patient who are treated with steroid (dexamethasone) injection through selected cervical spinal nerve block approach guided by ultrasound and C arm.
the patients who are treated with steroid (dexamethasone) injection through cervical transforaminal approach guided by ultrasound and C arm.
the patients who are treated with steroid (dexamethasone) injection through cervical transforaminal approach guided only by C arm.
Outcomes
Primary Outcome Measures
change of pain severity rated on a Visual Analog Scale (VAS)
Secondary Outcome Measures
change of neck actives rated on Neck Disability Index (NDI)
change of medication use rated on Medication Quantitative Scale (MQS)
Full Information
NCT ID
NCT02295709
First Posted
November 16, 2014
Last Updated
November 19, 2014
Sponsor
Shanghai Jiao Tong University Affiliated Sixth People's Hospital
1. Study Identification
Unique Protocol Identification Number
NCT02295709
Brief Title
Cervical Transforaminal Injection of Steroids Guided by Ultrasound
Official Title
Cervical Transforaminal Injection of Steroids Guided by Ultrasound
Study Type
Interventional
2. Study Status
Record Verification Date
November 2014
Overall Recruitment Status
Unknown status
Study Start Date
January 2014 (undefined)
Primary Completion Date
January 2015 (Anticipated)
Study Completion Date
March 2015 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Shanghai Jiao Tong University Affiliated Sixth People's Hospital
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Cervical transforaminal epidural steroid injections (TFESI) are indicated in cervical radicular pain resistant to conservation therapy, by which steroids can be delivered into anterior epidural space surrounding target spinal nerve roots to help alleviate pain in the upper limb or neck. Cervical TFESI is traditionally commended to perform with guidance of fluoroscopy or CT. As fluoroscopy can not monitor the injection route whether it pass vessel or not, many serious neurological complications caused by inadvertent intra-arterial injection have been reported2. Here, the investigators will introduce a novel cervical TFESI guided by ultrasound, which incidence of inadvertent vessel injury or injection might be lower than those guided by fluoroscopy.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cervical Radiculopathy
Keywords
ultrasound, cervical Transformational Epidural Steroid Injection
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
60 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
USNR steroid injection
Arm Type
Experimental
Arm Description
the patient who are treated with steroid (dexamethasone) injection through selected cervical spinal nerve block approach guided by ultrasound and C arm.
Arm Title
UCTF steroid injection
Arm Type
Experimental
Arm Description
the patients who are treated with steroid (dexamethasone) injection through cervical transforaminal approach guided by ultrasound and C arm.
Arm Title
XCTF steroid injection
Arm Type
Experimental
Arm Description
the patients who are treated with steroid (dexamethasone) injection through cervical transforaminal approach guided only by C arm.
Intervention Type
Procedure
Intervention Name(s)
SNR steroid (dexamethasone) injection
Intervention Description
deliver steroids (dexamethasone) into spinal nerve root with the guidance of ultrasound.
Device: Ultrasound (S-Nerve; SonoSite, Bothell, Wash), Probe 9L (6 MHz, SonoSite, Bothell, Wash)
Intervention Type
Procedure
Intervention Name(s)
CTF steroid (dexamethasone) injection
Intervention Description
deliver steroids (dexamethasone) into spinal epidural space with the guidance of ultrasound.
Device: Ultrasound (S-Nerve; SonoSite, Bothell, Wash), Probe 9L (6 MHz, SonoSite, Bothell, Wash)
Intervention Type
Drug
Intervention Name(s)
Dexamethasone
Other Intervention Name(s)
DXM
Intervention Description
One of the most efficient steroids
Intervention Type
Device
Intervention Name(s)
Ultrasound
Intervention Description
Ultrasound (S-Nerve; SonoSite, Bothell, Wash), Probe 9L (6 MHz, SonoSite, Bothell, Wash)
Intervention Type
Radiation
Intervention Name(s)
C arm
Intervention Description
the needle position will be re-confirmed by C arm C arm (Philips Healthcare, Best, the Netherlands)
Primary Outcome Measure Information:
Title
change of pain severity rated on a Visual Analog Scale (VAS)
Time Frame
1 day before, 1day after, 1week after and 4 weeks after the intervention
Secondary Outcome Measure Information:
Title
change of neck actives rated on Neck Disability Index (NDI)
Time Frame
1 day before, 1day after, 1week after and 4 weeks after the intervention
Title
change of medication use rated on Medication Quantitative Scale (MQS)
Time Frame
1 day before, 1day after, 1week after and 4 weeks after the intervention
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
evidence of a cervical radiculopathy involving 1 spinal nerve of at least 1 month's duration refractory to medical treatment
symptoms of cervical pain radiating to the upper limb
and signs of altered sensations, ab- normal reflexes, or motor weakness caused by degenerative spondylosis and/or disk herniation as documented at CT or MR imaging and a current mean pain VAS score of six.
Exclusion criteria:
evidence of vertebral fracture, tumor, or infection of the cervical spine
treatment with cervical corticosteroid injections within the past 3 months
coagulopathy
allergy to iodinated contrast media.
12. IPD Sharing Statement
Learn more about this trial
Cervical Transforaminal Injection of Steroids Guided by Ultrasound
We'll reach out to this number within 24 hrs